Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

UNKNOWN 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Advanced Cancer 2Glioblastoma 1

Interventions

Nivolumab 8Paclitaxel 6Sirolimus 5Bevacizumab 5temsirolimus 4Pemetrexed 4Ipilimumab 4Docetaxel 4Carboplatin 4ARRY-334543 4Gemcitabine 3Erlotinib Hydrochloride 3olaparib 2linrodostat 2apatinib 2anlotinib 2abemaciclib 2Vorinostat 2Sunitinib 2Magnetic Resonance Spectroscopy 2Irinotecan 2Everolimus 2Doxorubicin 2Dasatinib 2Chlorogenic Acid 2Cetuximab 26-(6-(1-methyl-1H-pyrazol-4-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-ylsulfanyl)quinoline 2vorolanib 1vistusertib 1trametinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Advanced Cancer × Chlorogenic Acid × Clear all
NCT02245204 2018-11-21

Phase I Studies of Chlorogenic Acid for Injection for Tolerance and Pharmacokinetic of Advanced Cancers

Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd

Phase 1 Completed
8 enrolled

Advanced Cancer

NCT02136342 2014-10-21

Phase 1 Trial of Chlorogenic Acid in Patients With Advanced Cancer

ChineseAMS

Phase 1 Terminated

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡